Advanced company searchLink opens in new window

COLONIS PHARMA LIMITED

Company number 05486832

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
27 Jun 2024 CS01 Confirmation statement made on 18 June 2024 with no updates
24 Jun 2024 AP01 Appointment of Mr Nihad Hasagic as a director on 19 June 2024
16 May 2024 AP03 Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024
10 Apr 2024 AA Audit exemption subsidiary accounts made up to 30 June 2023
10 Apr 2024 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 30/06/23
10 Apr 2024 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 30/06/23
10 Apr 2024 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 30/06/23
20 Jun 2023 CS01 Confirmation statement made on 18 June 2023 with no updates
05 May 2023 AA Audit exemption subsidiary accounts made up to 30 June 2022
05 May 2023 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 30/06/22
05 May 2023 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 30/06/22
05 May 2023 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 30/06/22
06 Mar 2023 AP01 Appointment of Mr Richard John Paling as a director on 6 March 2023
27 Feb 2023 CH01 Director's details changed for Ipatia Efraimidou on 24 June 2021
01 Feb 2023 TM02 Termination of appointment of Amanda Miller as a secretary on 16 January 2023
09 Sep 2022 MR01 Registration of charge 054868320005, created on 7 September 2022
08 Jul 2022 CS01 Confirmation statement made on 18 June 2022 with updates
01 Apr 2022 AA Audit exemption subsidiary accounts made up to 30 June 2021
01 Apr 2022 PARENT_ACC Consolidated accounts of parent company for subsidiary company period ending 30/06/21
01 Apr 2022 AGREEMENT2 Notice of agreement to exemption from audit of accounts for period ending 30/06/21
01 Apr 2022 GUARANTEE2 Audit exemption statement of guarantee by parent company for period ending 30/06/21
18 Mar 2022 TM01 Termination of appointment of Julia Carolina Von Samson Himmelstjerna as a director on 14 February 2022
03 Dec 2021 PSC07 Cessation of Quantum Pharmaceutical Limited as a person with significant control on 25 June 2021
03 Dec 2021 PSC02 Notification of Clinigen Healthcare Limited as a person with significant control on 25 June 2021
12 Aug 2021 AD01 Registered office address changed from 25 Bedford Square Bloomsbury London WC1B 3HW United Kingdom to 25 Bedford Square Bloomsbury London WC1B 3HH on 12 August 2021